Resistance of lipoproteins from continuous ambulatory peritoneal dialysis patients to in vitro oxidation

Metabolism: Clinical and Experimental

Volumn 46, Issue 7, 1997, Pages 833-839

  Serdyuk, Anatole P ^a   Morton, Richard E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATHEROSCLEROSIS; AUTOOXIDATION; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CORONARY RISK; DERIVATIZATION; DRUG BLOOD LEVEL; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY FAILURE; LIPOPROTEIN METABOLISM; PRIORITY JOURNAL; PROTEIN MODIFICATION; UREMIA;

EID: 0030757217     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90131-1     Document Type: Article

References (46)

1. Gokal R, King J, Bogle S, et al: Outcome in patients on continuous ambulatory peritoneal dialysis and hemodialysis: 4-year analysis of a prospective multicenter study. Lancet 2:1105-1109, 1987
2. Thomas ME, Moorhead JF: Lipids in CAPD: A review, in Coles GA, Davies M, Williams JD (eds): CAPD: Host Defense, Nutrition and Ultraffltration. Basel, Switzerland, Karger Basel, 1990, pp 92-99
3. Ramos JM, Heaton A, McGurk JG, et al: Sequential changes in serum lipids and their subfractions in patients receiving continuous ambulatory peritoneal dialysis. Nephron 35:20-23, 1993
4. Lindholm B, Norbeck HE: Serum lipids and lipoproteins during continuous ambulatory peritoneal dialysis. Acta Med Scand 220:143-251, 1986
5. Oreopoulos DG, Khanna R, Williams P, et al: Continuous ambulatory peritoneal dialysis-1981. Nephron 30:293-303, 1982
6. Chisolm GM III, Penn MS: Oxidized lipoproteins and atherosclerosis, in Fuster V, Ross R, Topol EJ (eds): Atherosclerosis and Coronary Artery Disease. Philadelphia, PA, Lippincott-Raven, 1996, pp 129-149
7. Esterbauer H, Dieber-Rotheneder M, Waeg G, et al: Biochemical, structural, and functional properties of oxidized low density lipoprotein. Chem Res Toxicol 3:77-92, 1990
8. Witztum JL, Steinberg D: Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88:1785-1792, 1991
9. Liu K, Cuddy TE, Pierce GN: Oxidative status of lipoproteins in coronary disease patients. Am Heart J 123:285-290, 1992
10. Regnstrom J, Nilsson J, Tornvall P, et al: Susceptibility to low density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 339:1183-1186, 1992
11. La Ville AE, Sola R, Balanya J, et al: In vitro oxidized HDL is recognised by the scavenger receptors of macrophages: Implications for its protective role in vivo. Atherosclerosis 105:179-189, 1994
12. Nagano Y, Arai H, Kita T: High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. Proc Natl Acad Sci USA 88:6457-6461, 1991
13. Salmon S, Maziere C, Auclair M, et al: Malondialdehyde modification and copper-induced autooxidation of high density lipoprotein decrease cholesterol efflux from human cultured fibroblasts. Biochim Biophys Acta 1125:230-235, 1992
14. Thomas MJ, Thornburg T, Manning J, et al: Fatty acid composition of low-density lipoprotein influences its susceptibility to autooxidation. Biochemistry 33:1828-1834, 1994
15. Maggi E, Bellazzi R, Falaschi F, et al: Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis? Kidney Int 45:876-883, 1994
16. Toborek M, Wasik T, Drozdz M, et al: Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure. Metabolism 41:1229-1232, 1992
17. Loughrey CM, Young IS, McEnemy J, et al: Oxidation of low density lipoprotein in patients on regular hemodialysis. Atherosclerosis 110:185-193, 1994
18. Kuroda M, Asaka S, Tofuku Y, et al: Serum antioxidant activity in uremic patients. Nephron 41:293-2908, 1985
19. Richard MJ, Arnaud J, Jurkovitz C, et al: Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron 57:10-15, 1991
20. Maggi E, Bellazi R, Gazo A, et al: Autoantibodies against oxidatively modified LDL in uremic patients undergoing dialysis. Kidney Int 46:869-876, 1994
21. Sanderson KJ, van Rij AM, Wade CR, et al: Lipid peroxidation of circulating low density lipoproteins with age, smoking and in peripheral vascular disease. Atherosclerosis 118:45-51, 1995
22. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, National Cholesterol Education Program: Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 89:1329-1445, 1994
23. Havel RJ, Eder HA, Bragdon JH: The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34:1345-1353, 1955
24. Esterbauer H, Gebicki J, Puhl H, et al: The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 13:341-390, 1992
25. Esterbauer H, Striegl G, Puhl H, et al: The role of vitamin E and carotenoids in preventing oxidation of low density lipoproteins. Ann NY Acad Sci 570:254-267, 1989
26. Maggi E, Chiesa R, Melissano G, et al: LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers. Arterioscler Thromb 14:1892-1899, 1994
27. El-Saadani M, Esterbauer H, El-Sayed M, et al: A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res 30:627-630, 1989
28. Cominacini L, Garbin U, Davoli A, et al: A simple test for predisposition to LDL oxidation based on the fluorescence development during copper-catalyzed oxidative modification. J Lipid Res 32:349-358, 1991
29. Lowry OH, Rosebrough NJ, Farr AL, et al: Protein measurement with the Polin phenol reagent. J Biol Chem 193:265-275, 1951
30. Peterson GL: A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83:346-356, 1977
31. Van Lente F, Daher R, Waletzky JA: Vitamin E compared with other potential risk factor concentrations in patients with and without coronary artery disease: A case-matched study. Eur J Clin Chem Clin Biochem 32:585-587, 1994
32. Christie WW: Lipid Analysis. Isolation, Separation, Identification and Structural Analysis of Lipids. New York, NY. Pergamon, 1982, pp 51-92
33. Ghosh S, Basu MK, Schweppe JS: Agarose gel electrophoresis of serum lipoproteins. Determination of true mobility, isoelectric point and molecular size. Anal Biochem 50:592-601, 1972
34. Noguchi N, Niki E: Apolipoprotein B protein oxidation in low-density lipoproteins. Methods Enzymol 233:490-494, 1994
35. Nichols AV, Krauss RM, Musliner TA: Nondenaturing polyacrylamide gel electrophoresis. Methods Enzymol 128:417-431, 1986
36. Esterbauer H, Jurgens G, Quehenberger O, et al: Autooxidation of human low density lipoprotein: Loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J Lipid Res 28:495-509, 1987
37. Thomas CE, Jackson RL: Lipid hydroperoxide involvement in copper-dependent and -independent oxidation of low density lipoproteins. J Pharmacol Exp Ther 256:1182-1188, 1991
38. O'Leary V, Darley-Usmar VM, Russell LJ, et al: Pro-oxidant effects of lipoxygenase-derived peroxides on the copper-initiated oxidation of low-density lipoprotein. Biochem J 282:631-634, 1992
39. Mackness MI, Abbott C, Arrol S, et al: The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation. Biochem J 294:829-834, 1993
40. Parthasarathy S, Barnett J, Fong LG: High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1044:275-283, 1990
41. Lynch SM, Frei B: Mechanisms of copper- and iron-dependent oxidative modification of human low density lipoprotein. J Lipid Res 34:1745-1753, 1993
42. Lenz ML, Hudges H, Mitchell JR, et al: Lipid hydroperoxy and hydroxy derivatives in copper-catalyzed oxidation of low density lipoprotein. J Lipid Res 31:1043-1050, 1990
43. Esterbauer H, Puhl H, Dieber-Rotheneder M, et al: Effect of antioxidants on oxidative modification of LDL. Ann Med 23:573-578, 1991
44. Scheek LM, Wiseman SA, Tijburg LBM, et al: Dialysis of isolated low density lipoprotein induces a loss of lipophilic antioxidants and increases the susceptibility to oxidation in vitro. Atherosclerosis 117:139-144, 1995
45. Henry PD: Antiperoxidative actions of calcium antagonists and atherogenesis. J Cardiovasc Pharmacol 18:S6-S10, 1991 (suppl 1)
46. Raal FJ, Areias AJ, Waisberg R, et al: Susceptibility of low density lipoprotein to oxidation in familial hypercholesterolaemia. Atherosclerosis 115:9-15, 1995